188 related articles for article (PubMed ID: 15166671)
1. Carcinoma arising from preexisting pregnancy-like and cystic hypersecretory hyperplasia lesions of the breast: a clinicopathologic study of 9 patients.
Shin SJ; Rosen PP
Am J Surg Pathol; 2004 Jun; 28(6):789-93. PubMed ID: 15166671
[TBL] [Abstract][Full Text] [Related]
2. Pregnancy-like (pseudolactational) hyperplasia: a primary diagnosis in mammographically detected lesions of the breast and its relationship to cystic hypersecretory hyperplasia.
Shin SJ; Rosen PP
Am J Surg Pathol; 2000 Dec; 24(12):1670-4. PubMed ID: 11117789
[TBL] [Abstract][Full Text] [Related]
3. [Clinicopathologic features of cystic hypersecretory lesion of the breast].
Bi R; Cheng Y; Yu B; Shui R; Yang W; Xu X
Zhonghua Bing Li Xue Za Zhi; 2014 Jan; 43(1):25-9. PubMed ID: 24713245
[TBL] [Abstract][Full Text] [Related]
4. Cystic hypersecretory hyperplasia and cystic hypersecretory duct carcinoma of the breast. Pathology, therapy, and follow-up of 39 patients.
Guerry P; Erlandson RA; Rosen PP
Cancer; 1988 Apr; 61(8):1611-20. PubMed ID: 2832048
[TBL] [Abstract][Full Text] [Related]
5. Coexistence of pregnancy-like and cystic hypersecretory hyperplasia with invasive lobular carcinoma.
Takeuchi T; Tsuzuki H; Numoto S; Furihata M
Onkologie; 2011; 34(8-9):448-50. PubMed ID: 21934345
[TBL] [Abstract][Full Text] [Related]
6. Cancerization of small ectatic ducts of the breast by ductal carcinoma in situ cells with apocrine snouts: a lesion associated with tubular carcinoma.
Goldstein NS; O'Malley BA
Am J Clin Pathol; 1997 May; 107(5):561-6. PubMed ID: 9128269
[TBL] [Abstract][Full Text] [Related]
7. Clinicopathologic analysis of breast lesions associated with multiple papillomas.
Ali-Fehmi R; Carolin K; Wallis T; Visscher DW
Hum Pathol; 2003 Mar; 34(3):234-9. PubMed ID: 12673557
[TBL] [Abstract][Full Text] [Related]
8. Invasive cystic hypersecretory carcinoma of the breast: a rare variant of breast cancer: a case report and review of the literature.
Sun J; Wang X; Wang C
BMC Cancer; 2019 Jan; 19(1):31. PubMed ID: 30621638
[TBL] [Abstract][Full Text] [Related]
9. Invasive cystic hypersecretory carcinoma of the breast: a case report.
Lee JS; Lee YJ
J Korean Med Sci; 2004 Feb; 19(1):149-51. PubMed ID: 14966360
[TBL] [Abstract][Full Text] [Related]
10. Columnar alteration with prominent apical snouts and secretions: a spectrum of changes frequently present in breast biopsies performed for microcalcifications.
Fraser JL; Raza S; Chorny K; Connolly JL; Schnitt SJ
Am J Surg Pathol; 1998 Dec; 22(12):1521-7. PubMed ID: 9850178
[TBL] [Abstract][Full Text] [Related]
11. Lobular carcinoma in situ diagnosed by core needle biopsy: when should it be excised?
Middleton LP; Grant S; Stephens T; Stelling CB; Sneige N; Sahin AA
Mod Pathol; 2003 Feb; 16(2):120-9. PubMed ID: 12591964
[TBL] [Abstract][Full Text] [Related]
12. Atypical ductal hyperplasia in breast core needle biopsies. Correlation of size of the lesion, complete removal of the lesion, and the incidence of carcinoma in follow-up biopsies.
Renshaw AA; Cartagena N; Schenkman RH; Derhagopian RP; Gould EW
Am J Clin Pathol; 2001 Jul; 116(1):92-6. PubMed ID: 11447758
[TBL] [Abstract][Full Text] [Related]
13. Association of breast cancer with the finding of atypical ductal hyperplasia at core breast biopsy.
Moore MM; Hargett CW; Hanks JB; Fajardo LL; Harvey JA; Frierson HF; Slingluff CL
Ann Surg; 1997 Jun; 225(6):726-31; discussion 731-3. PubMed ID: 9230813
[TBL] [Abstract][Full Text] [Related]
14. Cystic hypersecretory (in situ) carcinoma of the breast: a clinicopathologic and immunohistochemical characterization of 10 cases with clinical follow-up.
D'Alfonso TM; Ginter PS; Liu YF; Shin SJ
Am J Surg Pathol; 2014 Jan; 38(1):45-53. PubMed ID: 24121179
[TBL] [Abstract][Full Text] [Related]
15. The role of sentinel node biopsy in ductal carcinoma in situ of the breast.
Polom K; Murawa D; Wasiewicz J; Nowakowski W; Murawa P
Eur J Surg Oncol; 2009 Jan; 35(1):43-7. PubMed ID: 18723312
[TBL] [Abstract][Full Text] [Related]
16. Is core needle biopsy superior to fine-needle aspiration biopsy in the diagnosis of papillary breast lesions?
Masood S; Loya A; Khalbuss W
Diagn Cytopathol; 2003 Jun; 28(6):329-34. PubMed ID: 12768640
[TBL] [Abstract][Full Text] [Related]
17. Atypical ductal hyperplasia diagnosed at stereotaxic core biopsy of breast lesions: an indication for surgical biopsy.
Liberman L; Cohen MA; Dershaw DD; Abramson AF; Hann LE; Rosen PP
AJR Am J Roentgenol; 1995 May; 164(5):1111-3. PubMed ID: 7717215
[TBL] [Abstract][Full Text] [Related]
18. Predictors of invasive breast cancer in patients with an initial diagnosis of ductal carcinoma in situ: a guide to selective use of sentinel lymph node biopsy in management of ductal carcinoma in situ.
Yen TW; Hunt KK; Ross MI; Mirza NQ; Babiera GV; Meric-Bernstam F; Singletary SE; Symmans WF; Giordano SH; Feig BW; Ames FC; Kuerer HM
J Am Coll Surg; 2005 Apr; 200(4):516-26. PubMed ID: 15804465
[TBL] [Abstract][Full Text] [Related]
19. Long term clinical follow-up of atypical ductal hyperplasia and lobular carcinoma in situ in breast core needle biopsies.
Renshaw AA; Gould EW
Pathology; 2016 Jan; 48(1):25-9. PubMed ID: 27020205
[TBL] [Abstract][Full Text] [Related]
20. When is a diagnosis of sclerosing adenosis acceptable at core biopsy?
Gill HK; Ioffe OB; Berg WA
Radiology; 2003 Jul; 228(1):50-7. PubMed ID: 12738875
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
